Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19413 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von J O Gordilho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita, Rituximab. Die Arbeit nennt 10 Literaturangaben. Gefördert von: CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), FUNADERSP (Fundo de Apoio à Dermatologia do Estado de São Paulo), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
- Department of Ophthalmology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
- Department of Otorhinolaryngology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
- Department of Gastroenterology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
- Department of Ginecology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
- Department of Infectious Diseases, Faculdade de Medicina FMUSP, Universidade de São Paulo, Sao Paulo, SP, Brazil.
ORCID-Profile: J O Gordilho, V Aoki
Förderung
- CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior)
- FUNADERSP (Fundo de Apoio à Dermatologia do Estado de São Paulo)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Gordilho, J. O., Miyamoto, D., Maruta, C. W., Santo, R. M., Mahmoud, A., Navarro-Rodriguez, T., Werneck-Silva, A. L., de Aguiar, L. M., Borges, I. C., Santi, C. G., & Aoki, V. (2024). Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19413
Vancouver
Gordilho JO, Miyamoto D, Maruta CW, Santo RM, Mahmoud A, Navarro-Rodriguez T, et al. Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19413
BibTeX
@article{Gordilho2024,
author = {Gordilho, J O and Miyamoto, D and Maruta, C W and Santo, R M and Mahmoud, A and Navarro-Rodriguez, T and Werneck-Silva, A L and de Aguiar, L M and Borges, I C and Santi, C G and Aoki, V},
title = {Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19413}
}
EUVIMED